Purifloh Ltd (PO3)

Announcements

Company Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Directors & Management

Name	Title	Since	Bio
Dr Alex Sava	Non-Executive Director	Apr 2021	Dr Alex Sava Non-Executive Director Dr Sava has over 35 years' experience in microbiology, chemistry and biochemistry. He also has experience in commercializing his numerous inventions internationally. He is holding over 100 international patents and authoring over 50 scientific articles. 'From invention to consumer' he was involved in development of over 50 commercial products distributed worldwide by 3M, Ecolab and Getinge.
Mr Jonathon (Jon) Evans	Non-Executive Director	Oct 2020	Mr Jonathon (Jon) Evans Non-Executive Director Mr Evans has a range of experience in healthcare, medical research and the innovation and commercialisation of IP and related technology solutions across the Australian and broader Asia Pacific Region. His career spans over 30 years, including as CEO of an Australian Hospital Group; Director of a State-based Infectious Disease Reference Laboratory; CEO of Tellimed Health Services; Director of Health Strategy and Innovation for Victorian Government; Managing Partner of Fitzroy Health Asia Pacific- an Australian/US Health Commercialisation company and most recently as Managing Director, APAC Health Solutions Group. Mr Evans is also chairman of CEMTAS Australia.
Mr Carl Le Souef	Non-Executive Director,Interim Chairman	Nov 2019	Mr Carl Le Souef Non-Executive Director,Interim Chairman Mr Souef is a founding partner and co-owner of Somnio Global. He oversaw the restructuring of PuriflOH (previously known as Water Resources Group Limited) during 2013/2014, which resulted in Dilato Holdings Pty Limited emerge as the major shareholder of PuriflOH, a position it still retains. Dilato Holdings is Mr. Le Souef's private investment company. Mr. Le Souef was previously the sole owner and CEO of one of Australia's largest privately owned FMCG organisations, Private Formula International, a global operation that included Australia's number one selling skincare range at the time, Dr LeWinn's Private Formula. In 2009, he negotiated the sale of the company to a US based pharmaceutical major. Mr Le Souef maintains an executive role in Somnio Global and in the management of his family office investments.
Mr Simon Richard Lill	Executive Director,Company Secretary	Sep 2013	Mr Simon Richard Lill Executive Director,Company Secretary Mr Lill has a background of over 30 years of stockbroking, capital raising, management, business development and analysis for a range of small and start-up companies, in both the manufacturing and resources industries. He has assisted Mr Le Souef in the restructuring of the Company in 2013 and has managed the Company's Australian affairs since that time. He has similarly assisted the restructure of De Grey Mining Limited from his appointment in 2013 and is now Chairman of that Company. Mr Lill has been, or is, a director of the following: De Grey Mining Limited (appointed 2 October 2013, continuing) Mejority Capital Limited (appointed 18 May 2010; resigned 25 November 2019) XPD Soccer Gear Group Limited (appointed 29 March 2018, continuing).

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
20/05/20	Simon Lill	Buy	+2,000	$2.30	$4,600	On-market trade
15/05/20	Simon Lill	Buy	+2,970	$2.25	$6,682	On-market trade
22/11/19	Simon Lill	Issued	32,500	$2.40	$78,000	Director remuneration
22/11/19	William (Bill) Parfet	Issued	11,684	$3.72	$43,467	Director remuneration

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Alex Sava	22/04/2021	108,950	N/A	N/A	N/A
Carl Le Souef	30/06/2020	N/A	18,409,194	N/A	N/A
Simon Lill	30/06/2020	288,720	N/A	N/A	N/A
Jonathon (Jon) Evans	N/A	N/A	N/A	N/A	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Dilato Holdings Pty Ltd	18,409,194	58.66%
Upjohn Laboratories Llc	5,271,601	16.80%
Andra M Rush	650,000	2.07%
Holbrook Corporation Pty Ltd	402,206	1.28%
Riveck Nominees Pty Ltd	342,555	1.09%
Gemtara Investments Pty Ltd	305,576	0.97%
Citicorp Nominees Pty Limited	291,445	0.93%
Steven Annear	285,597	0.91%
Targo Holdings Pty Ltd	245,250	0.78%
HSBC Custody Nominees (Australia) Limited	241,855	0.77%
Lampam Pty Ltd	170,000	0.54%
Hopetoun Nominees Pty Ltd	166,000	0.53%
Anthony Mark Van Der Steeg	164,921	0.53%
Malcolm Richmond	159,965	0.51%
Saul Zaidman	140,445	0.45%
Isamg Pty Ltd	135,850	0.43%
Ferkel Pty Ltd	121,100	0.39%
Raymond Micallef	114,000	0.36%
Credal International Ltd	113,895	0.36%
Ranchland Holdings Pty Ltd	100,000	0.32%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$2.90	30 June
2019	$3.35	28 June
2018	$0.435	29 June

PO3 Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.